Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2016

01.02.2016 | original article

A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria

verfasst von: Dr. Luigi Segagni Lusignani, Dr. Alexander Blacky, Dr. Peter Starzengruber, Ass. Prof. Magda Diab-Elschahawi, MD, Msc, Dipl. Ing. Thomas Wrba, Prof. Elisabeth Presterl

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2016

Einloggen, um Zugang zu erhalten

Summary

Background

The first point prevalence survey performed in Austria had the aim to assess the magnitude of healthcare-associated infections and antimicrobials use in the country.

Methods

A multicentre study was carried out from May until June 2012 in nine acute care hospitals with a mean bed number of 620. Data from 4321 patients’ clinical charts were reviewed.

Results

The overall healthcare-associated infections prevalence was 6.2 % (268/4321) with the highest rate in intensive care departments (20.9 %; 49/234). In medical and surgical departments the healthcare-associated infections prevalence was 5.4 % (95/1745) and 6.6 % (105/1586), respectively. The most frequent healthcare-associated infections were: urinary tract infections (21.3 %; 61/287), pneumonia (20.6 %; 59/287) and surgical site infections (17.4 %; 50/287). The most common isolated microorganisms were: Escherichia coli (14.8 %; 26/176), Enterococcus species (13.1 %; 23/176) and Pseudomonas aeruginosa (11.4 %; 20/176). Thirty-three per cent (1425/4321) of the patients received antimicrobials because of community-acquired infections treatment (14.2 %; 615/4321), healthcare-associated infections treatment (6.4 %; 278/4321), and surgical (8.2 %; 354/4321) and medical prophylaxis (3.2 %; 138/4321). Surgical prophylaxis was the indication for 22.0 % (394/1792) of the overall prescriptions and was prolonged for more than 1 day in 77.2 % (304/394) of the cases.

Conclusion

The national Austrian survey proved the feasibility of a nation-wide network of surveillance of both healthcare-associated infections and antimicrobial use that will be repeated in the future. Healthcare-associated infections and antimicrobial use have been confirmed to be a grave health problem. The excessive prolongation of perioperative prophylaxis in Austria needs to be limited.
Literatur
1.
Zurück zum Zitat Annual epidemiological report on communicable diseases in Europe 2008. Report on the state of communicable diseases in the EU and EEA/EFTA countries. Stockholm: European Centre for Disease Prevention and Control, Stockholm, 2008. ISBN 978-92-9193-137-8. ISSN 1830-6160. doi:10.2900/22770. Annual epidemiological report on communicable diseases in Europe 2008. Report on the state of communicable diseases in the EU and EEA/EFTA countries. Stockholm: European Centre for Disease Prevention and Control, Stockholm, 2008. ISBN 978-92-9193-137-8. ISSN 1830-6160. doi:10.2900/22770.
2.
Zurück zum Zitat Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14. doi:10.1086/657912.CrossRefPubMed Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14. doi:10.​1086/​657912.CrossRefPubMed
3.
Zurück zum Zitat Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54(4):258–66. quiz 321.CrossRefPubMed Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54(4):258–66. quiz 321.CrossRefPubMed
4.
Zurück zum Zitat Plowman R. The socio-economic burden of hospital acquired infection. Euro Surveill. 2000;5(4):49–50.PubMed Plowman R. The socio-economic burden of hospital acquired infection. Euro Surveill. 2000;5(4):49–50.PubMed
5.
Zurück zum Zitat Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–21.PubMedCentralCrossRefPubMed Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–21.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Collignon P. Clinical impact of antimicrobial resistance in humans. Rev Sci Tech. 2012;31(1):211–20.PubMed Collignon P. Clinical impact of antimicrobial resistance in humans. Rev Sci Tech. 2012;31(1):211–20.PubMed
7.
Zurück zum Zitat Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals Protocol, Technical document. European Centre for Disease Prevention and Control, Stockholm, 2012. ISBN 978-92-9193-366-2 .doi:10.2900/53482. Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals Protocol, Technical document. European Centre for Disease Prevention and Control, Stockholm, 2012. ISBN 978-92-9193-366-2 .doi:10.2900/53482.
8.
Zurück zum Zitat McCabe WR, Jackson GG. Gram negative bacteremia: etiology and ecology. Arch Intern Med. 1962;110:847–852.CrossRef McCabe WR, Jackson GG. Gram negative bacteremia: etiology and ecology. Arch Intern Med. 1962;110:847–852.CrossRef
13.
Zurück zum Zitat Haley RW, Morgan WM, Culver DH. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Am J Infect Control. 1985;13(3):97–108.CrossRefPubMed Haley RW, Morgan WM, Culver DH. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Am J Infect Control. 1985;13(3):97–108.CrossRefPubMed
15.
Zurück zum Zitat Flodgren G, Conterno LO, Mayhew A, Omar O, Pereira CR, Shepperd S. Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database Syst Rev. 2013;3:CD006559. doi:10.1002/14651858.PubMed Flodgren G, Conterno LO, Mayhew A, Omar O, Pereira CR, Shepperd S. Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database Syst Rev. 2013;3:CD006559. doi:10.​1002/​14651858.PubMed
17.
18.
Zurück zum Zitat Nosokomiale Infektionen in Österreich 2013. Vienna: Nationales Referenzzentrum für Nosokomiale Infektionen und Antibiotikaresistenz. 2013. In press. Nosokomiale Infektionen in Österreich 2013. Vienna: Nationales Referenzzentrum für Nosokomiale Infektionen und Antibiotikaresistenz. 2013. In press.
19.
Zurück zum Zitat Starzengruber P, Segagni Lusignani L, Wrba T, et al. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Wien Klin Wochenschr. 2014;126(13–14):427–30. doi:10.1007/s00508-014-0549-x.CrossRefPubMed Starzengruber P, Segagni Lusignani L, Wrba T, et al. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Wien Klin Wochenschr. 2014;126(13–14):427–30. doi:10.​1007/​s00508-014-0549-x.CrossRefPubMed
21.
Zurück zum Zitat Bratzler D, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 2013;70(3):195–283.CrossRefPubMed Bratzler D, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 2013;70(3):195–283.CrossRefPubMed
22.
Zurück zum Zitat Wang F, Chen XZ, Liu J, et al. Short-term versus long-term administration of single prophylactic antibiotic in elective gastric tumor surgery. Hepatogastroenterology. 2012;59(118):1784–8. doi:10.5754/hge11784.PubMed Wang F, Chen XZ, Liu J, et al. Short-term versus long-term administration of single prophylactic antibiotic in elective gastric tumor surgery. Hepatogastroenterology. 2012;59(118):1784–8. doi:10.​5754/​hge11784.PubMed
24.
Zurück zum Zitat McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998;68(6):388–96.CrossRefPubMed McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998;68(6):388–96.CrossRefPubMed
25.
Zurück zum Zitat Humphreys H, Smyth ET. Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? Clin Microbiol Infect. 2006;12(1):2–4.CrossRefPubMed Humphreys H, Smyth ET. Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? Clin Microbiol Infect. 2006;12(1):2–4.CrossRefPubMed
27.
Zurück zum Zitat Spencer RC. Prevalence studies in nosocomial infections. Eur J Clin Microbiol Infect Dis. 1992;11(2):95–8.CrossRefPubMed Spencer RC. Prevalence studies in nosocomial infections. Eur J Clin Microbiol Infect Dis. 1992;11(2):95–8.CrossRefPubMed
Metadaten
Titel
A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria
verfasst von
Dr. Luigi Segagni Lusignani
Dr. Alexander Blacky
Dr. Peter Starzengruber
Ass. Prof. Magda Diab-Elschahawi, MD, Msc
Dipl. Ing. Thomas Wrba
Prof. Elisabeth Presterl
Publikationsdatum
01.02.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0947-8

Weitere Artikel der Ausgabe 3-4/2016

Wiener klinische Wochenschrift 3-4/2016 Zur Ausgabe